News Express: UM scholar elected fellow of Royal Society of Biology
新聞快訊：澳大學者榮膺英國皇家生物學會會士
陳修平
Chen Xiuping
澳大學者榮膺英國皇家生物學會會士
澳門大學中華醫藥研究院教授陳修平當選為英國皇家生物學會會士，彰顯他在生物醫學領域取得的傑出成就，也反映了澳大中華醫藥研究院在推動醫藥研究創新方面，取得具國際影響力的研究成果。
英國皇家生物學會（The Royal Society of Biology）致力於推動與生命科學相關的教育和學術活動及生物科技發展，是全球具有重大影響力的生物學組織之一。每年會頒發會士名銜予在相關領域擁有影響力的科學家，以表揚學者在科研或社會福祉上的卓越成績。
陳修平長期從事藥理學研究，致力於抗癌、抗炎和心腦血管保護的新藥研發。首次提出新型非凋亡的程式性細胞死亡方式-Noptosis，開闢了程式性細胞死亡研究的新方向。Elsevier公佈的全球頂尖科學家藥學學科名單中，位列中國入選的175位學者中的第53名。陳修平於2022年全球學者庫國內藥學學科百名領軍人物排行64名，在《British Journal of Pharmacology》《Medicinal Research Reviews》《Pharmacology & Therapeutics》等藥理學經典雜誌發表SCI 論文150餘篇，引用超過11,000餘次，H-Index 57。2013年他獲第17屆中國藥理學會施維雅青年藥理學工作者，並主持國家自然科學基金項目3項，以及澳門科學技術發展基金項目多項。同時，他也擔任國家自然科學基金評審專家、香港RGC基金評審專家、中國藥理學會理事等。
欲瀏覽官網版可登入以下連結:
https://www.um.edu.mo/zh-hant/news-and-press-releases/campus-news/detail/54963/
UM scholar elected fellow of Royal Society of Biology
Chen Xiuping, professor in the Institute of Chinese Medical Sciences (ICMS) of the University of Macau (UM), has been elected fellow of the Royal Society of Biology for his distinguished contributions to the field of biomedical sciences. The achievement of fellow status of Prof Chen is also testament to the leading role of the ICMS in driving innovations and generating impactful research results recognised by the international academia.
As one of the most influential biological organisations in the world, the Royal Society of Biology is committed to promoting educational and academic activities related to life sciences, as well as the development of biotechnology. The society awards fellowships every year to influential scientists with outstanding contributions to their fields of research or to society around the globe.
Prof Chen has been dedicated to pharmacology research for years, with a focus on the development of new drugs for the treatment of cancer, inflammatory, and cardiovascular diseases. He proposed a novel non-apoptotic programmed cell death method, Noptosis, which has opened up a new subfield in the research of programmed cell death. Prof Chen is ranked No 53 among the 175 top scholars in the pharmaceutical discipline in China by Elsevier and No 64 among the top 100 pharmaceutical leaders of China in the Global Scholars Database in 2022. He has published more than 150 SCI papers in top pharmacological journals such as the British Journal of Pharmacology, Medicinal Research Reviews, and Pharmacology & Therapeutics, with more than 11,000 citations and an h-index of 57. In 2013, Prof Chen received the SERVIER Young Pharmacologist Award from the 17th Chinese Pharmacological Society. He has been awarded three projects from the National Natural Science Foundation of China (NSFC) and a number of projects from the Macao Science and Technology Development Fund. In addition, Prof Chen is a project reviewer for NSFC and the Hong Kong Research Grants Council, as well as a council member of the Chinese Pharmacological Society.
To read the news on UM’s official website, please visit the following link:
https://www.um.edu.mo/news-and-press-releases/campus-news/detail/54963/